Immunotech Biopharm Ltd

HKEX:6978.HK

1.6 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018
Revenue 000000
Cost of Revenue 000000
Gross Profit 000000
Gross Profit Ratio 000000
Reseach & Development Expenses 177.32669.7693.6278.62661.97531.172
General & Administrative Expenses 53.22397.708104.254106.20836.82911.647
Selling & Marketing Expenses 00000.0011.119
SG&A 53.22397.708104.254106.20836.82911.647
Other Expenses 0101.362137.736-1.60512.0570.069
Operating Expenses 230.549268.83335.59383.229110.86142.43
Operating Income -230.549-280.235-333.354-419.834-110.144-42.43
Operating Income Ratio 000000
Total Other Income Expenses Net -104.93-47.164-9.751-91.878-18.757.542
Income Before Tax -335.479-321.095-354.615-439.129-109.054-34.888
Income Before Tax Ratio 000000
Income Tax Expense 031.73920.8719.213-1.3438.677
Net Income -334.819-352.834-375.485-458.342-107.711-34.766
Net Income Ratio 000000
EPS -0.65-0.69-0.73-1.03-0.22-0.07
EPS Diluted -0.65-0.69-0.73-1.03-0.22-0.07
EBITDA -178.83-236.164-324.332-333.986-86.789-42.321
EBITDA Ratio 000000